Sfoglia per Autore
Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells
2002 Scotlandi K.; Avnet S.; Benini S.; Manara M.C.; Serra M.; Cerisano V.; Perdichizzi S.; Lollini P.-L.; De Giovanni C.; Landuzzi L.; Picci P.
Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: Implication for cell-based therapy in bone defect reconstruction
2003 Beccheroni A.; Lucarelli E.; Donati D.; Sangiorgi L.; Capponcelli S.; Gorini M.; Bertoja A.Z.; Giardino R.; Mercuri M.; Ferrari S.; Bacci G.; Picci P.
Platelet-derived growth factors enhance proliferation of human stromal stem cells
2003 Lucarelli E.; Beccheroni A.; Donati D.; Sangiorgi L.; Cenacchi A.; Del Vento A.M.; Meotti C.; Bertoja A.Z.; Giardino R.; Fornasari P.M.; Mercuri M.; Picci P.
Evoluzione dei trattamenti integrati nei sarcomi dei tessuti molli all'Istituto Ortopedico Rizzoli
2004 F.Gherlinzoni; P.Picci; M.Mercuri; G.Bacci; S. Frustaci; A. De Polis; E.Barbieri
Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators.
2004 CERISANO V; AALTO Y; PERDICHIZZI S; BERNARD G; MANARA MC; BENINI S; CENACCHI G.; PREDA P; LATTANZI G; NAGY B; KNUUTILA S; COLOMBO MP; BERNARD A; PICCI P; SCOTLANDI K.
Sarcomi delle parti molli. Tredici anni di esperienza dell'Istituto Ortopedico Rizzoli - Sarcomas of the soft tissues. Thirteen years of experience at the Rizzoli Orthopaedic Institute.
2004 Ferraro A; Biagini R; Ruggieri P; De Paolis M; Gigli M; Errani C; Barbieri E; Picci P; Mercuri M.
Second malignancy in 597 patients with Ewing Sarcoma of Bone treated and a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999
2005 G.Bacci; A.Longhi; E.Barbieri; S.Ferrari; M.Mercuri; A.Briccoli; M.Versari; E.Pienotti; P.Picci
Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation.
2005 Capponcelli S.; Pedrini E.; Cerone M.A.; Corti V.; Fontanesi S.; Alessio M.; Bachi A.; Soddu S.; Ribatti D.; Picci P.; Helman L.J.; Cantelli Forti G.; Sangiorgi L.
Insulin-like growth factor binding protein 3 as an anti-cancer molecule in Ewing's sarcoma.
2006 S. Benini; M. Zuntini; M.C. Manara; P. Cohen; G. Nicoletti; P. Nanni; Y Oh; P. Picci; K. Scotlandi
CD99 Acts as an Oncosuppressor in Osteosarcoma.
2006 Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.; Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K.
Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcoma
2006 K. Scotlandi; S. Perdichizzi; G. Bernard; G. Nicoletti; P. Nanni; P.-L. Lollini; A. Curti; M. C. Manara; S. Benini; A. Bernard; P. Picci
Adjiuvant treatment of high-risk adult soft tissue sarcomas: a survey by the Italian Sarcoma Group
2006 S. Frustaci; M. Beretta; A. Comandone; E. Bidoli; A. De Paoli; F. Gherlinzoni; T. De Pas; E. Barbieri; M. Pertici; G. Apice; P. Picci
Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients
2006 Bacci, Gaetano; Fabbri, N.; Balladelli, A.; Forni, C.; Palmerini, E.; Picci, P.
Molecular alterations of monophasic synovial sarcoma: Loss of chromosome 3p does not alter RASSF1 and MLH1 transcriptional activity
2006 Pazzaglia, L.; Benassi, Maria Serena; Ragazzini, P.; Gamberi, G.; Ponticelli, F.; Chiechi, A.; Hattinger, C.M.; Morandi, L.; Alberghini, M.; Zanella, L.; Picci, P.; Mercuri, M.
Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant chemotherapy between 1972 and 1999
2006 G. Bacci; A. Longhi; S. Ferrari; M. Mercuri; E. Barbieri; F. Bertoni; P. Bacchini; P. Picci
CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity
2007 Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni P; Lollini PL; Bernard A; Picci P
Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing’s sarcoma.
2007 M.C. Manara; L. Landuzzi; P. Nanni; G. Nicoletti; D. Zambelli; P.L. Lollini; C. Nanni; F. Hofmann; C. García-Echeverría; P. Picci; K. Scotlandi.
Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases
2007 G. Bacci; A. Longhi; C. Forni; N. Fabbri; A. Briccoli; E. Barbieri; M. Mercuri; A. Balladelli; S. Ferrari; P. Picci
Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: The rizzoli institute experience
2008 Bacci G; Balladelli A; Palmerini E; Alberghini M; Pollastri P; Galletti S; Mercuri M; Picci P.
Hemangioendotelioma of Bone: a review of the Rizzoli Experience
2009 ALBERGHINI M; RUGGIERI P; ANGELINI A; USSIAG; GAMBAROTTI M; FERRARI S; VANEL D; PICCI P; MERCURI M
| Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File |
|---|---|---|---|---|---|---|
| Expression of an IGF-I receptor dominant negative mutant induces apoptosis, inhibits tumorigenesis and enhances chemosensitivity in Ewing's sarcoma cells | Scotlandi K.; Avnet S.; Benini S.; Manara M.C.; Serra M.; Cerisano V.; Perdichizzi S.; Lollini P....-L.; De Giovanni C.; Landuzzi L.; Picci P. | 2002-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Recovery of stromal stem cells in bone sarcoma patients after chemotherapy: Implication for cell-based therapy in bone defect reconstruction | Beccheroni A.; Lucarelli E.; Donati D.; Sangiorgi L.; Capponcelli S.; Gorini M.; Bertoja A.Z.; Gi...ardino R.; Mercuri M.; Ferrari S.; Bacci G.; Picci P. | 2003-01-01 | ONCOLOGY REPORTS | - | 1.01 Articolo in rivista | - |
| Platelet-derived growth factors enhance proliferation of human stromal stem cells | Lucarelli E.; Beccheroni A.; Donati D.; Sangiorgi L.; Cenacchi A.; Del Vento A.M.; Meotti C.; Ber...toja A.Z.; Giardino R.; Fornasari P.M.; Mercuri M.; Picci P. | 2003-01-01 | BIOMATERIALS | - | 1.01 Articolo in rivista | - |
| Evoluzione dei trattamenti integrati nei sarcomi dei tessuti molli all'Istituto Ortopedico Rizzoli | F.Gherlinzoni; P.Picci; M.Mercuri; G.Bacci; S. Frustaci; A. De Polis; E.Barbieri | 2004-01-01 | LA CHIRURGIA DEGLI ORGANI DI MOVIMENTO | - | 1.01 Articolo in rivista | - |
| Molecular mechanisms of CD99-induced caspase-independent cell death and cell-cell adhesion in Ewing's sarcoma cells: actin and zyxin as key intracellular mediators. | CERISANO V; AALTO Y; PERDICHIZZI S; BERNARD G; MANARA MC; BENINI S; CENACCHI G.; PREDA P; LATTANZ...I G; NAGY B; KNUUTILA S; COLOMBO MP; BERNARD A; PICCI P; SCOTLANDI K. | 2004-01-01 | ONCOGENE | - | 1.01 Articolo in rivista | - |
| Sarcomi delle parti molli. Tredici anni di esperienza dell'Istituto Ortopedico Rizzoli - Sarcomas of the soft tissues. Thirteen years of experience at the Rizzoli Orthopaedic Institute. | Ferraro A; Biagini R; Ruggieri P; De Paolis M; Gigli M; Errani C; Barbieri E; Picci P; Mercuri M. | 2004-01-01 | LA CHIRURGIA DEGLI ORGANI DI MOVIMENTO | - | 1.01 Articolo in rivista | - |
| Second malignancy in 597 patients with Ewing Sarcoma of Bone treated and a single institution with adjuvant and neoadjuvant chemotherapy between 1972 and 1999 | G.Bacci; A.Longhi; E.Barbieri; S.Ferrari; M.Mercuri; A.Briccoli; M.Versari; E.Pienotti; P.Picci | 2005-01-01 | JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation. | Capponcelli S.; Pedrini E.; Cerone M.A.; Corti V.; Fontanesi S.; Alessio M.; Bachi A.; Soddu S.; ...Ribatti D.; Picci P.; Helman L.J.; Cantelli Forti G.; Sangiorgi L. | 2005-01-01 | HUMAN MUTATION | - | 1.01 Articolo in rivista | - |
| Insulin-like growth factor binding protein 3 as an anti-cancer molecule in Ewing's sarcoma. | S. Benini; M. Zuntini; M.C. Manara; P. Cohen; G. Nicoletti; P. Nanni; Y Oh; P. Picci; K. Scotlandi | 2006-01-01 | INTERNATIONAL JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| CD99 Acts as an Oncosuppressor in Osteosarcoma. | Manara M.C.; Bernard G.; Lollini P.L.; Nanni P.; Zuntini M.; Landuzzi L.; Benini S.; Lattanzi G.;... Sciandra M.; Serra M.; Colombo M.P.; Bernard A.; Picci P.; Scotlandi K. | 2006-01-01 | MOLECULAR BIOLOGY OF THE CELL | - | 1.01 Articolo in rivista | - |
| Targeting CD99 in association with doxorubicin: An effective combined treatment for Ewing’s sarcoma | K. Scotlandi; S. Perdichizzi; G. Bernard; G. Nicoletti; P. Nanni; P.-L. Lollini; A. Curti; M. C. ...Manara; S. Benini; A. Bernard; P. Picci | 2006-01-01 | EUROPEAN JOURNAL OF CANCER | - | 1.01 Articolo in rivista | - |
| Adjiuvant treatment of high-risk adult soft tissue sarcomas: a survey by the Italian Sarcoma Group | S. Frustaci; M. Beretta; A. Comandone; E. Bidoli; A. De Paoli; F. Gherlinzoni; T. De Pas; E. Barb...ieri; M. Pertici; G. Apice; P. Picci | 2006-01-01 | TUMORI | - | 1.01 Articolo in rivista | - |
| Treatment and prognosis for synchronous multifocal osteosarcoma in 42 patients | Bacci, Gaetano; Fabbri, N.; Balladelli, A.; Forni, C.; Palmerini, E.; Picci, P. | 2006-01-01 | JOURNAL OF BONE AND JOINT SURGERY-BRITISH VOLUME | - | 1.01 Articolo in rivista | - |
| Molecular alterations of monophasic synovial sarcoma: Loss of chromosome 3p does not alter RASSF1 and MLH1 transcriptional activity | Pazzaglia, L.; Benassi, Maria Serena; Ragazzini, P.; Gamberi, G.; Ponticelli, F.; Chiechi, A.; Ha...ttinger, C.M.; Morandi, L.; Alberghini, M.; Zanella, L.; Picci, P.; Mercuri, M. | 2006-01-01 | HISTOLOGY AND HISTOPATHOLOGY | - | 1.01 Articolo in rivista | - |
| Pattern of relapse in 290 patients with nonmetastatic Ewing's sarcoma family tumors treated at a single institution with adjuvant chemotherapy between 1972 and 1999 | G. Bacci; A. Longhi; S. Ferrari; M. Mercuri; E. Barbieri; F. Bertoni; P. Bacchini; P. Picci | 2006-01-01 | EUROPEAN JOURNAL OF ONCOLOGY | - | 1.01 Articolo in rivista | - |
| CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity | Scotlandi K; Zuntini M; Manara MC; Sciandra M; Rocchi A; Benini S; Nicoletti G; Bernard G; Nanni ...P; Lollini PL; Bernard A; Picci P | 2007-01-01 | ONCOGENE | - | 1.01 Articolo in rivista | - |
| Preclinical in vivo study of new insulin-like growth factor-I receptor-specific inhibitor in Ewing’s sarcoma. | M.C. Manara; L. Landuzzi; P. Nanni; G. Nicoletti; D. Zambelli; P.L. Lollini; C. Nanni; F. Hofmann...; C. García-Echeverría; P. Picci; K. Scotlandi. | 2007-01-01 | CLINICAL CANCER RESEARCH | - | 1.01 Articolo in rivista | - |
| Neoadjuvant chemotherapy for radioinduced osteosarcoma of the extremity: The Rizzoli experience in 20 cases | G. Bacci; A. Longhi; C. Forni; N. Fabbri; A. Briccoli; E. Barbieri; M. Mercuri; A. Balladelli; S.... Ferrari; P. Picci | 2007-01-01 | INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | - | 1.01 Articolo in rivista | - |
| Neoadjuvant chemotherapy for osteosarcoma of the extremities in preadolescent patients: The rizzoli institute experience | Bacci G; Balladelli A; Palmerini E; Alberghini M; Pollastri P; Galletti S; Mercuri M; Picci P. | 2008-01-01 | JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY | - | 1.01 Articolo in rivista | - |
| Hemangioendotelioma of Bone: a review of the Rizzoli Experience | ALBERGHINI M; RUGGIERI P; ANGELINI A; USSIAG; GAMBAROTTI M; FERRARI S; VANEL D; PICCI P; MERCURI M | 2009-01-01 | - | s.n | 2.01 Capitolo / saggio in libro | - |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile